Cover image of the article: Singapore's Experience With Buprenorphine

Image Credit:Iran J Psychiatry Behav Sci

Singapore's Experience With Buprenorphine

Authors

Alireza Noroozi1,*, Fahimeh Mianji2
1Psychiatrist, Senior Medical Officer of Treatment Programs. Room No 510. 5th Floor, Substance Abuse Prevention and Treatment Office (SAPTO), Deputy for Health (DH), Ministry of Health, Treatment and Medical Education, Hafez St., Tehran, Iran
2Department of Psychology, Tonekabon Azad University, Tonekabon, Iran
*Corresponding Author: Psychiatrist, Senior Medical Officer of Treatment Programs. Room No 510. 5th Floor, Substance Abuse Prevention and Treatment Office (SAPTO), Deputy for Health (DH), Ministry of Health, Treatment and Medical Education, Hafez St., Tehran, Iran, Tel: +98-2166709082, Fax: +98-2166700410 Email: a_r_noroozi@yahoo.co

IJ Psychiatry and Behavioral Sciences:Vol. 2, issue 1; 54-9
Published online:Jan 31, 2008
Article type:Brief Report
Received:Dec 01, 2007
Accepted:Dec 31, 2007
How to Cite:Noroozi A, Mianji F. Singapore's Experience With Buprenorphine. Iran J Psychiatry Behav Sci. 2008;2(1):. doi:

Abstract

Buprenorphine (Subutex) has been used to treat opioid dependency in the past 16 years. Subutex (or buprenorphine hydrochloride) was approved by the Singapore's Ministry of Health (MOH) in 2000 as a substitution treatment for opiate-dependent drug abusers within the framework of medical, social and psychological treatments. It was subsequently introduced into the Singapore market in 2002. In spite of the promise of improvement in the lives of addicts with medical care, a distinct trend of buprenorphine abuse has occurred. A cascade of events from 2002 to 2006 led to discontinuation of Subutex treatment programs in the country. In this paper, firstly reports on morbidity and mortality caused by Subutex IV abuse will be reviewed and secondly, the MOH response to the situation will be outlined and finally, implications of Singapore’s experience with Subutex will be discussed

Highlights

Fulltext

Full text is available in the PDF.

References

  • 1.
    References are available in the PDF.

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

19
Apr
2025
Intranasal Use of Buprenorphine: A Case Report on Non-sublingual Routes and Associated Risks from Iran

Intranasal Use of Buprenorphine: A Case Report on Non-sublingual Routes and Associated Risks from Iran

Omid Massah,
Seyed Ramin Radfar,
Ali Farhoudian

Massah O, Radfar SR, Farhoudian A. Intranasal Use of Buprenorphine: A Case Report on Non-sublingual Routes and Associated Risks from Iran. Iran J Psychiatry Behav Sci. 2025;19(2):e157802. doi: https://doi.org/10.5812/ijpbs-157802

19
Feb
2018
Pain and Sleep Measures in Methadone and in Suboxone Patients

Pain and Sleep Measures in Methadone and in Suboxone Patients

Gamal Sadek,
Zack Cernovsky,
Simon Chiu,
Yves Bureau,
Sandra Mekhaiel

Sadek G, Cernovsky Z, Chiu S, Bureau Y, Mekhaiel S. Pain and Sleep Measures in Methadone and in Suboxone Patients. Int J High Risk Behav Addict. 2018;7(1):e67609. doi: https://doi.org/10.5812/ijhrba.67609

20
Jan
2024
Diversity of Providing Services to Patients Suffering from Addiction Disorders is a Harm Reduction Thought, but...

Diversity of Providing Services to Patients Suffering from Addiction Disorders is a Harm Reduction Thought, but...

Nader Charkhgard,
Aida Afghani,
Shahram Naderi,
Shima Zahirian Moghadam,
Peyman Rad

Charkhgard N, Afghani A, Naderi S, Zahirian Moghadam S, Rad P. Diversity of Providing Services to Patients Suffering from Addiction Disorders is a Harm Reduction Thought, but.... Arch Neurosci. 2024;11(1):e143310. doi: https://doi.org/10.5812/ans-143310

7
Dec
2019
An Epidemic Problem: A Commentary on Stimulant Use in Opioid Maintenance Treatment

An Epidemic Problem: A Commentary on Stimulant Use in Opioid Maintenance Treatment

Saeed Nateghi,
Hosein Effatpanah

Nateghi S, Effatpanah H. An Epidemic Problem: A Commentary on Stimulant Use in Opioid Maintenance Treatment. Iran J Psychiatry Behav Sci. 2019;13(4):e97805. doi: https://doi.org/10.5812/ijpbs.97805

28
Jun
2016
The Investigation of Executive Functions in Patients under Methadone and Buprenorphine Maintenance Treatment

The Investigation of Executive Functions in Patients under Methadone and Buprenorphine Maintenance Treatment

Hossein Hatami,
Soheila Khoda karim,
Hamid Eghbali,
Mojtaba Rajabpour

Hatami H, Khoda karim S, Eghbali H, Rajabpour M. The Investigation of Executive Functions in Patients under Methadone and Buprenorphine Maintenance Treatment. koomesh. 2016;17(3):e151212. doi:

More by these authors

Alireza NorooziPubMedScholar
Fahimeh MianjiPubMedScholar
Share
Cited by
Metrics